Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohd Rehan

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Frontiers in Pharmacology|January 26, 2024
Computational insights into the stereo-selectivity of catechins for the inhibition of the cancer therapeutic target EGFR kinaseMohd Rehan, Firoz Ahmed, Mohammad Imran Khan, et al.
Toxics|December 22, 2022
Potential Disruption of Systemic Hormone Transport by Tobacco Alkaloids Using Computational ApproachesMohd Rehan, Ummer R Zargar, Ishfaq A Sheikh, et al.
Journal of Biomolecular Structure & Dynamics|August 3, 2017
Cationic surfactant mediated fibrillogenesis in bovine liver catalase: a biophysical approachMohsin Vahid Khan, Masihuz Zaman, Tajalli Ilm Chandel, et al.
Antioxidants (Basel, Switzerland)|March 25, 2022
Venetoclax-Resistant MV4-11 Leukemic Cells Activate PI3K/AKT Pathway for Metabolic Reprogramming and Redox Adaptation for SurvivalHind A Alkhatabi, Samir F Zohny, Mohammed Razeeth Shait Mohammed, et al.
Scientific Reports|October 17, 2023
Unlocking potential inhibitors for Bruton's tyrosine kinase through in-silico drug repurposing strategiesMohammed Alrouji, Lizy Sonia Benjamin, Fahad A Alhumaydhi, et al.
Frontiers in Immunology|July 12, 2021
A Computational Approach Identified Andrographolide as a Potential Drug for Suppressing COVID-19-Induced Cytokine StormMohd Rehan, Firoz Ahmed, Saad M Howladar, et al.
Plos One|March 4, 2014
Anticancer compound plumbagin and its molecular targets: a structural insight into the inhibitory mechanisms using computational approachesMohammad S Jamal, Shadma Parveen, Mohd A Beg, et al.
Journal of Biomolecular Structure & Dynamics|May 25, 2023
Visible-light promoted catalyst-free (VLCF) multi-component synthesis of spiro indolo-quinazolinone-pyrrolo[3,4-a]pyrrolizine hybrids: evaluation of <i>in vitro</i> anticancer activity, molecular docking, MD simulation and DFT studiesSafia Iqbal, Farhanaz, Roohi, et al.
Journal of Biomolecular Structure & Dynamics|May 8, 2025
Integrating transcriptomics with disease-gene network and identification of EGFR kinase target: inhibitor discovery through virtual screening of natural compounds for brain cancer therapyMohd Rehan, Wejdan M AlZahrani, Firoz Ahmed, et al.
Frontiers in Genetics|August 22, 2022
Structural-Guided Identification of Small Molecule Inhibitor of UHRF1 Methyltransferase ActivityMd Abdul Awal, Suza Mohammad Nur, Ali Khalaf Al Khalaf, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Frontiers in Pharmacology|January 26, 2024
Computational insights into the stereo-selectivity of catechins for the inhibition of the cancer therapeutic target EGFR kinaseMohd Rehan, Firoz Ahmed, Mohammad Imran Khan, et al.
Toxics|December 22, 2022
Potential Disruption of Systemic Hormone Transport by Tobacco Alkaloids Using Computational ApproachesMohd Rehan, Ummer R Zargar, Ishfaq A Sheikh, et al.
Journal of Biomolecular Structure & Dynamics|August 3, 2017
Cationic surfactant mediated fibrillogenesis in bovine liver catalase: a biophysical approachMohsin Vahid Khan, Masihuz Zaman, Tajalli Ilm Chandel, et al.
Antioxidants (Basel, Switzerland)|March 25, 2022
Venetoclax-Resistant MV4-11 Leukemic Cells Activate PI3K/AKT Pathway for Metabolic Reprogramming and Redox Adaptation for SurvivalHind A Alkhatabi, Samir F Zohny, Mohammed Razeeth Shait Mohammed, et al.
Scientific Reports|October 17, 2023
Unlocking potential inhibitors for Bruton's tyrosine kinase through in-silico drug repurposing strategiesMohammed Alrouji, Lizy Sonia Benjamin, Fahad A Alhumaydhi, et al.
Frontiers in Immunology|July 12, 2021
A Computational Approach Identified Andrographolide as a Potential Drug for Suppressing COVID-19-Induced Cytokine StormMohd Rehan, Firoz Ahmed, Saad M Howladar, et al.
Plos One|March 4, 2014
Anticancer compound plumbagin and its molecular targets: a structural insight into the inhibitory mechanisms using computational approachesMohammad S Jamal, Shadma Parveen, Mohd A Beg, et al.
Journal of Biomolecular Structure & Dynamics|May 25, 2023
Visible-light promoted catalyst-free (VLCF) multi-component synthesis of spiro indolo-quinazolinone-pyrrolo[3,4-a]pyrrolizine hybrids: evaluation of <i>in vitro</i> anticancer activity, molecular docking, MD simulation and DFT studiesSafia Iqbal, Farhanaz, Roohi, et al.
Journal of Biomolecular Structure & Dynamics|May 8, 2025
Integrating transcriptomics with disease-gene network and identification of EGFR kinase target: inhibitor discovery through virtual screening of natural compounds for brain cancer therapyMohd Rehan, Wejdan M AlZahrani, Firoz Ahmed, et al.
Frontiers in Genetics|August 22, 2022
Structural-Guided Identification of Small Molecule Inhibitor of UHRF1 Methyltransferase ActivityMd Abdul Awal, Suza Mohammad Nur, Ali Khalaf Al Khalaf, et al.
Pageof 9